IM011021: A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy and Safetyof BMS-986165 in Subjects with Systemic Lupus Erythematosus

Project: Research project

Project Details

Description

IM011021: A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy and Safety of BMS-986165 in Subjects with Systemic Lupus Erythematosus
StatusActive
Effective start/end date2/1/1812/31/21

Funding

  • BRISTOL-MYERS SQUIBB COMPANY

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.